HookE.B., WarburtonD.The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism.Hum Genet1983; 64: 24–7.
3.
SaengerP.Clinical review 48: the current status of diagnosis and therapeutic intervention in Turner's syndrome.J Clin Endocrinol Metab1993; 77: 297–301.
4.
SchoemakerM.J., SwerdlowA.J., HigginsC.D., WrightA.F., JacobsP.A.Mortality in women with Turner syndrome in Great Britain: a national cohort study.J Clin Endocrinol Metab2008; 93: 4735–42.
5.
FlynnM.T., EkstromL., De ArceM., CostiganC., HoeyH.M.Prevalence of renal malformation in Turner syndrome.Pediatr Nephrol1996; 10: 498–500.
6.
LippeB., GeffnerM.E., DietrichR.B., BoechatM.I., KangarlooH.Renal malformations in patients with Turner syndrome: imaging in 141 patients.Pediatrics1988; 82: 852–6.
7.
CarvalhoA.B., Guerra JúniorG., BaptistaM.T., de FariaA.P., MariniS.H., GuerraA.T.Cardiovascular and renal anomalies in Turner syndrome.Rev Assoc Med Bras2010; 56: 655–9.
8.
JelicS., MarisavljevicD.Turner's syndrome with mosaic karyotype and renovascular hypertension [Serbian].Srp Arh Celok Lek1997; 125: 48–50.
9.
GoodyerP.R., FongJ.S., KaplanB.S.Turner's syndrome, 46X, del (X) (p 11), persistent complement activation and membranoproliferative glomerulonephritis.Am J Nephrol1982; 2: 272–5.
